HyperCVAD方案治疗成人高危急性淋巴细胞白血病的疗效观察
被引量:5
摘要
随着化疗以及支持治疗的改进,成人急性淋巴细胞白血病(ALL)的完全缓解(CR)率达80%~90%,但长期无病生存(DFS)率仅30%~40%,有相当部分的患者缓解后仍会复发。根据预后和风险因素调整ALL的治疗是ALL的现代治疗策略。我们自2003年3月开始对14例高危ALL患者进行HyperCVAD方案诱导治疗,取得了较好的疗效。
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2008年第1期52-53,共2页
Chinese Journal of Hematology
基金
江苏省社会发展计划基金(BS2005024)
苏州大学医学发展基金(EE122508)
参考文献5
-
1Avivi I, Rowe JM. Acute lymphocytic leukemia: role of hemat poietic stem cell transplantation in current management. Curr Opin Hematol, 2003,10 : 463-468.
-
2靳凤艳,邹德慧,王国蓉,徐燕,冯四洲,赵耀中,韩明哲,严文伟,邱录贵.成人急性淋巴细胞白血病缓解后化疗和自体造血干细胞移植疗效的比较[J].中华血液学杂志,2005,26(11):645-648. 被引量:16
-
3Beutler E, Lichtma MA, Williams WJ, et al. Williams Hematology. 6th ed. 北京:人民卫生出版社,2001:1154-1155.
-
4Thomas X, Boiron JM, Huguet F, et al. Outcome of treatment in adults with acute lymphoblastic leukemia : analysis of the LALA-94 trial. J Clin Oncol, 2004, 22: 4075-4086.
-
5Kantarjian HM, O' Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oneol, 2000,18:547-561.
二级参考文献10
-
1邱录贵,严文伟,韩明哲,冯四洲,李成文,郝玉书.早期连续强化巩固治疗后自体骨髓移植治疗成人急性淋巴细胞白血病[J].中华血液学杂志,1996,17(10):507-510. 被引量:6
-
2Ludwing WD, Rieder H, Bartram CR, et al. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German Multicenter Trials GMALL 03/87 and 04/89. Blood, 1998, 92: 1898-1909.
-
3Thiebaut A, Vernant JP, Degos L, et al. Adult acute lymphoblastic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.Hematol Oncol Clin North Am, 2000, 14: 1353-1366.
-
4Bassan R, Pogliani E, Lerede T, et al. Fractionated cyclophosphamide added to the IVAP regimen ( idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase Ⅱ clinical study. Haematologica, 1999, 84: 1088-1093.
-
5Fiere D, Lepage E, Sebban C, et al. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. J Clin Oncol, 1993, 11:1990-2001.
-
6Gorin NC. Autologous stem cell transplantation in acute lymphocytic leukemia. Stem Cells, 2002, 20: 3-10.
-
7Uckun FM, Kersey JH, Haake R, et al. Autologous bone marrow transplantation in high-risk B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, BA-3/CD10 ) plus complement and 4-hydroperoxycyclo-phosphamide for ex vivo bone marrow purging. Blood, 1992, 79:1094-1104.
-
8Vivancos P, Granena A Jr, Sarra J, et al. Treatment with interleukin-2 ( IL-2 ) and interferon ( IFN ( alpha 2b) ) after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse. Bone Marrow Transplant, 1999, 23: 169-172.
-
9Powles R, Sirohi B, Treleaven J, et al. The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia. Blood, 2002, 100:1641-1647.
-
10Granados E, de La Camara R, Madero L, et al. Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation. Haematologica, 2000, 85:1060-1067.
共引文献15
-
1傅华睿,黄河.哪些急性白血病患者适合造血干细胞移植?[J].中华移植杂志(电子版),2010,4(2):127-131. 被引量:4
-
2田秀英,王丽,闫红.蒙药治疗白血病化疗抑制期感染的临床观察[J].中国民族医药杂志,2006,12(3):21-21.
-
3王国蓉,徐燕,邹德慧,赵耀中,王玫,韩明哲,冯四洲,严文伟,邱录贵.成人急性淋巴细胞白血病自体移植与异基因移植[J].中国医学科学院学报,2006,28(4):544-548. 被引量:2
-
4李妍,王迎,邹德慧,傅明伟,赵耀中,李新,王国蓉,邓书会,邱录贵.HyperCVAD/MA方案强化治疗31例淋巴系统肿瘤的初步临床观察[J].国际输血及血液学杂志,2007,30(2):122-127. 被引量:11
-
5赵永强,佘妙容.自体干细胞移植治疗第一次完全缓解的成人急性淋巴细胞白血病:LALA-85、LALA-87、LALA-94试验[J].循证医学,2007,7(4):200-202.
-
6贾国荣,贺其图,李志芹,马宏杰,李静,李哲,卢燕,云雁.自体外周血造血干细胞移植治疗急性淋巴细胞白血病一例[J].内蒙古医学杂志,2007,39(9):1126-1126.
-
7傅华睿(综述),黄河(审校).成人急性淋巴细胞白血病造血干细胞移植治疗的选择[J].国际输血及血液学杂志,2009(3):213-216.
-
8周仲昊,陆时运,王智.HyperCVAD方案治疗淋巴细胞白血病16例疗效分析[J].中国中医药咨讯,2010(34):193-194.
-
9田锦林.HyperCVAD方案治疗淋巴细胞白血病的临床疗效分析[J].当代医学,2011,17(4):77-78. 被引量:1
-
10赵利东,薛连国,王莹,蔡志梅,毛建平,贾韬,陈泽,刘惠杰.儿童方案治疗青少年及成人急性淋巴细胞白血病疗效分析[J].苏州大学学报(医学版),2011,31(4):686-688. 被引量:1
同被引文献32
-
1陈世伦.重视多发性骨髓瘤的规范化治疗[J].中华内科杂志,2005,44(2):81-82. 被引量:11
-
2靳凤艳,邹德慧,王国蓉,徐燕,冯四洲,赵耀中,韩明哲,严文伟,邱录贵.成人急性淋巴细胞白血病缓解后化疗和自体造血干细胞移植疗效的比较[J].中华血液学杂志,2005,26(11):645-648. 被引量:16
-
3姚庆民,侯明.大剂量地塞米松治疗特发性血小板减少性紫癜10年回顾[J].中华内科杂志,2006,45(10):871-872. 被引量:4
-
4李妍,王迎,邹德慧,傅明伟,赵耀中,李新,王国蓉,邓书会,邱录贵.HyperCVAD/MA方案强化治疗31例淋巴系统肿瘤的初步临床观察[J].国际输血及血液学杂志,2007,30(2):122-127. 被引量:11
-
5KANTARJIAN H,THOMAS D,O'BRIEN S,et al.Long-term follow-up results of hyperfracti0nated eyelophosphamide,vineristine,doxorubiein,and dexamethasone (Hyper CVAD).a dose-intensive regimen,in adult acute lymphocytic leukemia[J].Cancer,2004,101:2788-2801.
-
6Aviv I,Rowe JM.Acute lymphocytic leukemia:role of hematopoietic stem cell transplantation in current management[J].Ourr Opin Hematol,2005,10(6):463-468.
-
7Thomas X,Boi ron JM,Huguet F,et al.Outcome of treatment in adults with acute lymphoblastic leukemia:analysis of the LALA-94 trial[J].J Clin Oncol,2004,22(20):4075-4086.
-
8Kantarjian HM,O'Brien S,Smith TL,et al.Results of treatment with hyper-CVAD,a dose-intensive regimen,in adult acute lymphocytic leukemia[J].J Clin Oncol,2000,18(3):547-561.
-
9Avivi,Rowe JM.Acute lymphocytic leukemia:role of hematopoietic stem cell transplantation in current management.Curr Opin Hematol,2003,10,463-468.
-
10Thomas X,Boiron JM,Huguet F,et al.Outcome of treatment in adults with acute lymphoblastic leukemia:analysis of the LALA-94 trial.J Clin Oncol,2004,22:4075-4086.
引证文献5
-
1陈泽,刘惠杰,王莹,蔡志梅,阎冬梅,毛建平,贾韬,赵利东.急性淋巴细胞白血病诱导治疗缓解后用Hyper-CVAD方案治疗的疗效观察[J].临床血液学杂志,2010,23(2):112-113. 被引量:2
-
2周仲昊,陆时运,王智.HyperCVAD方案治疗淋巴细胞白血病16例疗效分析[J].中国中医药咨讯,2010(34):193-194.
-
3田锦林.HyperCVAD方案治疗淋巴细胞白血病的临床疗效分析[J].当代医学,2011,17(4):77-78. 被引量:1
-
4魏莉,黄莺,陈勤奋.大剂量地塞米松在血液系统疾病治疗中的应用[J].上海医药,2013,34(3):17-21. 被引量:4
-
5赵寅,王丹丹.白血病合并2型糖尿病患者化疗依从性相关影响因素及对策[J].中国临床研究,2023,36(5):792-796. 被引量:1
二级引证文献8
-
1秦晓铧,陈立,陈国枢,谢晓玲,黎国伟,许先吟.Hyper-CVAD方案治疗成人急性淋巴细胞白血病疗效分析[J].中国医药科学,2011,1(22):65-65. 被引量:3
-
2黄琨,徐敏,曹静.Hyper-CVAD/MA方案治疗淋巴系统恶性血液病20例临床分析[J].当代医学,2012,18(1):93-94.
-
3杨俊超,杨一飞,李丽,张瑞英,于艳芳,申娜,周晨光.沙利度胺联合川芎嗪及改良预激化疗方案治疗难治性急性白血病25例疗效分析[J].内科急危重症杂志,2013,19(5):301-302. 被引量:2
-
4朱春丽,黎海澜,王魏华,焦伟,莫柱宁.不同治疗方案对原发免疫性血小板减少症患者外周血调节T细胞水平变化的影响及其意义分析(英文)[J].现代生物医学进展,2015,15(4):718-722.
-
5沈海涛,李迥,尚淑玲,付爱军.中药汤剂藤草煎辅助治疗免疫性血小板减少症41例[J].贵阳中医学院学报,2015,37(3):28-31.
-
6吕晓娟,覃骏,柯鸿,龚晓丽.归脾汤加减治疗免疫性血小板减少症临床研究[J].中医学报,2016,31(8):1178-1181. 被引量:14
-
7叶惠成,刘玉华.改良Hyper-CVAD方案诱导治疗中老年pH阴性急性淋巴细胞白血病继发高血糖的临床研究[J].分子影像学杂志,2017,40(3):311-314. 被引量:2
-
8邹仕霞.LEARNS健康教育模式在急性白血病患者中的应用效果[J].医药前沿,2024,14(3):83-85.
-
1司玉玲,綦振家,王英娟.G-CSF治疗恶性血液病化疗后粒细胞减少的疗效观察[J].中国误诊学杂志,2003,3(11):1702-1703. 被引量:3
-
2徐卫,李建勇,钱思轩,陆化,吴汉新,仇红霞.Hyper-CVAD方案治疗35例高危急性淋巴细胞白血病疗效分析[J].中华内科杂志,2007,46(11):938-939. 被引量:9
-
3郭智,杨凯,陈惠仁,何学鹏,楼金星,刘晓东,陈鹏,张媛,陈竹.CVAD方案序贯治疗多发性骨髓瘤的临床研究[J].肿瘤研究与临床,2015,27(4):246-249. 被引量:8
-
4徐方元,韩道才.高危急性淋巴细胞白血病抢救成功1例报告[J].蚌埠医药,1989(1):93-93.
-
5刘开彦,陈奋,翁建宇.PETHEMA ALL-93研究结果:成人高危急性淋巴细胞白血病缓解后维持治疗、异基因和自体造血干细胞移植的疗效比较[J].循证医学,2007,7(4):196-199. 被引量:3
-
6陈荣华,郭树霞,张晓娟.HyperCVAD方案和CHOP/CHOP样方案治疗初发的外周T细胞淋巴瘤的疗效[J].中国实验血液学杂志,2016,24(1):80-83. 被引量:7
-
7谷敏,梁欣荃,祝平安.HyperCVAD方案和CHOP方案治疗外周T细胞淋巴瘤的效果分析[J].医学美学美容(中旬刊),2015,24(2):203-203.
-
8魏淑霞.大剂量甲氨蝶呤治疗急性淋巴细胞性白血病10例的护理体会[J].山西医药杂志(下半月),2011,40(10):1067-1068. 被引量:1
-
9贾永清,胡慧仙.伊马替尼联合HyperCVAD方案巩固治疗Ph阳性的急性淋巴细胞白血病疗效分析[J].浙江实用医学,2016,21(2):106-108. 被引量:2
-
10石艳,杨尧.高危急性淋巴细胞白血病L_1型合并左下肢静脉栓塞1例[J].中国小儿血液,2004,9(5):230-230.